The higher ability of PMNs of NASH patients in suppressing CD4+ and CD8+ T cells, over time, might contribute in reducing the immunological defense of liver tissue against damages thus taking part in the progression of the NAFL disease toward NASH. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.